The effect of cognitive hypnotherapy on preventing relapse to opium use in men under methadone treatment

Document Type : Original Article

Authors

1 Department of Psychiatry, Golestan Research Center of Psychiatry, Golestan University of Medical Sciences, Gorgan, Iran

2 Clinical Research Development Unit (CRDU)5 Azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran

3 Infertility and Reproductive Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran

10.34172/ahj.1694

Abstract

Background: Opium addiction is a global problem that is difficult to overcome and has a high relapse rate. Some studies have shown the effect of hypnosis in helping control withdrawal symptoms and reduce relapse. The present study aimed to investigate the effect of cognitive hypnotherapy on preventing relapse to opium use in men under methadone treatment.
Methods: This clinical trial was conducted on 34 opium addicts who were admitted to the Addiction Center of 5 AZAR GORGAN Hospital in 2024. The study population was selected from the referring patients using convenience sampling and was randomly assigned into two groups (methadone plus hypnosis) and a control (methadone only). Participants with negative urine were included in the study. Cognitive hypnotherapy was conducted, including 8 sessions (60 minutes) once a week. For all samples (intervention and control), before and after the intervention, 3 and 6 months later, a morphine test was performed, and questionnaires were completed using the Ernest Barratt Impulsiveness Scale and the Substance Craving Scale. The data were analyzed using SPSS-19 software. The significance level was considered at P < 0.05.
Findings: The rate of relapse in opium use and the mean impulsivity score in all of its dimensions in the hypnotherapy group was lower than that in the control group after the intervention, three and six months later, though it was not statistically significant (P > 0.05). Although the mean craving score in the two groups was not statistically significant, the craving score in the hypnotherapy group was lower than that in the control group (P > 0.05).
Conclusion: Cognitive hypnotherapy can help reduce the desire to use opiate drugs.

Highlights

Mohammad Zaman Kamkar(Google Scholar) (PubMed) 

Keywords


  1. Center for Substance Abuse Treatment. Medication- Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2005.
  2. Eslami Shahrbabaki M, Ziaaddini H, Hagh Doost AA, Ghasemi M, Eslami Shahrbabaki P, Alizadeh Nouri R, et al. Methadone treatment in Iranian opiate addicts: a preliminary report. Addict Health 2011;3(1-2):53–60.
  3. Shekarchizadeh H, Ekhtiari H, Khami MR, Virtanen JI. Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran. Harm Reduct J 2012;9:18. doi:10.1186/1477-7517-9-18
  4. Kassani A, Niazi M, Hassanzadeh J, Menati R. Survival Analysis of Drug Abuse Relapse in Addiction Treatment Centers. Int J High Risk Behav Addict 2015;4(3):e23402. doi:10.5812/ijhrba.23402
  5. Moore TM, Seavey A, Ritter K, McNulty JK, Gordon KC, Stuart GL. Ecological momentary assessment of the effects of craving and affect on risk for relapse during substance abuse treatment. Psychol Addict Behav 2014;28(2):619– 24. doi:10.1037/a0034127
  6. Afkar A, Rezvani SM, Sigaroudi AE. Measurement of factors influencing the relapse of addiction: a factor analysis. International Journal of High Risk Behaviors and Addiction 2017;6(3).
  7. Ischenko EV, Alekseeva EM. HYPNOSIS As An Alternative Form For Prevention Of Drug Addiction In Adolescents. InАктуальные проблемы профессиональной сферы в современном мире 2017(pp. 63-65).
  8. Häuser W, Hagl M, Schmierer A, Hansen E. The Efficacy, Safety and Applications of Medical Hypnosis. Dtsch Arztebl Int 2016;113(17):289–96. doi:10.3238/arztebl.2016.0289
  9. O’Keefe T. Clinical hypnotherapy for stopping drug and alcohol addiction: Building resilience in clients to reduce relapses and remain clean and sober. Australian Journal of Clinical Hypnotherapy & Hypnosis 2020;41(1):16–26.
  10. Li X, Chen L, Ma R, Wang H, Wan L, Bu J, et al. The neural mechanisms of immediate and follow-up of the treatment effect of hypnosis on smoking craving. Brain Imaging Behav 2020;14(5):1487–97. doi:10.1007/s11682-019- 00072-0
  11. Malik S, Mahmud Q, Rehman A, Malik S, Fayyaz M. Control of tobacco paan and naswaar addiction by hypnosis. Pak J Physiol 2017;13(3):48-9.
  12. Hashemi J, Beheshti B, Alizadeh J. The Effectiveness of Hypnotherapy in Relapse Prevention, Reduction of Impulsiveness, and Decrease of Craving in Treated Stimulant Users. Research on Addiction 2017;11(42):93-110.
  13. Shestopal I, Bramness JG. Effect of Hypnotherapy in Alcohol Use Disorder Compared With Motivational Interviewing: A Randomized Controlled Trial. Addictive Disorders & Their Treatment 2019;18:169 – 75.
  14. Ekhtiari H, Safaei H, Esmaeeli Djavid G, Atefvahid MK, Edalati H, Mokri A. Reliability and validity of Persian versions of Eysenck, Barratt, Dickman and Zuckerman Questionnaires in assessing risky and impulsive behaviors. Iranian journal of psychiatry and clinical psychology 2008;14(3):326-36.
  15. Gulati S, D’Costa YA, Zador L, Kunnumpurath S. Hypnosis for Substance Abuse. Substance Abuse: Inpatient and Outpatient Management for Every Clinician 2015:369-78. doi:10.1007/978-1-4939-1951-2_29
  16. Hasan FM, Zagarins SE, Pischke KM, Saiyed S, Bettencourt AM, Beal L, et al. Hypnotherapy is more effective than nicotine replacement therapy for smoking cessation: results of a randomized controlled trial. Complement Ther Med 2014;22(1):1–8. doi:10.1016/j.ctim.2013.12.012
  17. Golabadi M, Taban H, Yaghoubi M, Gholamrezaei A. Hypnotherapy in the Treatment of Opium Addiction: A Pilot Study. Integrative Medicine: A Clinician’s Journal 2012;11:19–23.
  18. Perry JL, Larson EB, German JP, Madden GJ, Carroll ME. Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology (Berl) 2005;178(2-3):193–201. doi:10.1007/s00213-004-1994-4
  19. Alizadeh S, Ghelichi Y, Rajabi A, Shahriari V. Inhibitory Response and Impulsivity in Opium Users. J-Gorgan-Univ- Med-Sci 2024;26(2):55-63. doi:10.61882/goums.26.2.55
  20. Kikhavandi S, Menati R, Kassani A, Menati W. Associated Factors with Addiction Relapse in Patients of Referring to Addiction Treatment Centers in Ilam: a Case-Control Study. Journal of Ilam University of Medical Sciences 2015;22(6):165–73.
  21. Rollins AL, O’Neill SJ, Davis KE, Devitt TS. Substance abuse relapse and factors associated with relapse in an inner-city sample of patients with dual diagnoses. Psychiatr Serv 2005;56(10):1274–81. doi:10.1176/appi. ps.56.10.1274